Cytori Therapeutics' IPO

Cytori Therapeutics raised a round of funding on August 11, 2000. Investors include Public.

Cytori Therapeutics, formerly MacroPore, is developing cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and other medical conditions. The c…

Articles about Cytori Therapeutics' IPO: